Advanced Medicine

Manufacture Bioprocessing - Upstream & Downstream

Continuing the Trend

12/13/2017

Cell therapy could be the next area to benefit from continuous production processes.

Manufacture Advanced Medicine

Believe in RNAi

11/22/2017 | Geert Cauwenbergh

Geert Cauwenbergh believes that RNAi could be the therapeutic of the future.

Manufacture Technology and Equipment

Mini Mimic

11/22/2017 | William Aryitey

Could body-on-chip platforms eventually replace current pre-clinical animal models?

Manufacture Advanced Medicine

Automating the Future

10/16/2017 | Kim Nelson

To ensure that cell therapy manufacture runs smoothly, the industry must embrace automation.

Manufacture Advanced Medicine

Getting Personal with Oncology

09/20/2017 | Joe Olechno

Ex vivo screening techniques could revolutionize cancer treatment.

Manufacture Contract Development Services

Twenty-First Century Cell Therapy

09/20/2017 | Denis Bedoret

When making advanced medicines, the cost of manufacture must be lower than reimbursement

Manufacture Standards & Regulation

Making Therapeutic History

09/20/2017 | William Aryitey

The FDA approval of Kymriah marks the first CAR-T cell-based gene therapy available in the US

Manufacture Drug Delivery

The Golden Touch

09/20/2017 | James Strachan

What does “manufacturing” drugs in the body mean for chemotherapy?

Manufacture Business Practice

Here’s to Shared Successes!

09/20/2017 | Stephanie Vine

This issue marks The Medicine Maker's third birthday!

Manufacture Bioprocessing - Upstream & Downstream

Banking on Cell Therapy

09/15/2017 | Steve Oh

Sitting down with Steve Oh from the Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR

...
38
39
40
41
42
...

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine